Literature DB >> 19406828

Inverse correlation between HPSE gene single nucleotide polymorphisms and heparanase expression: possibility of multiple levels of heparanase regulation.

Olga Ostrovsky1, Michael Korostishevsky, Itay Shafat, Margarita Mayorov, Neta Ilan, Israel Vlodavsky, Arnon Nagler.   

Abstract

Heparanase is an endo-beta-glucuronidase that specifically cleaves the saccharide chains of heparan sulfate proteoglycans. Heparanase plays important roles in processes such as angiogenesis, tumor metastasis, tissue repair and remodeling, inflammation and autoimmunity. Genetic variations of the heparanase gene (HPSE) have been associated with heparanase transcription level. The present study was undertaken to identify haplotype or single nucleotide polymorphisms (SNPs) genotype combinations that correlate with heparanase expression both at the mRNA and protein levels. For this purpose, 11 HPSE gene SNPs were genotyped among 108 healthy individuals. Five out of the eleven polymorphisms revealed an association between the SNPs and heparanase expression. SNP rs4693608 exhibited a strong evidence of association. Analysis of haplotypes distribution revealed that the combination of two SNPs (rs4693608 and rs4364254) disclosed the most significant result. This approach allowed segregation of possible genotype combinations to three groups that correlate with low (LR: GG-CC, GG-CT, GG-TT, GA-CC), intermediate (MR: GA-CT, GA-TT) and high (HR: AA-TT, AA-CT) heparanase expression. Unexpectedly, LR genotype combinations were associated with low mRNA expressions level and high heparanase concentration in plasma, while HR genotype combinations were associated with high expression of mRNA and low plasma protein level. Because the main site of activity of secreted active heparanase is the extracellular matrix and cell surface, the origin and functional significance of plasma heparanase remain to be investigated. The current study indicates that rs4693608 and rs4364254 SNPs are involved in the regulation of heparanase expression and provides the basis for further studies on the association between HPSE gene SNPs and disease outcome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19406828      PMCID: PMC2796676          DOI: 10.1189/jlb.1208735

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  60 in total

Review 1.  Heparanase: a key enzyme involved in cell invasion.

Authors:  C R Parish; C Freeman; M D Hulett
Journal:  Biochim Biophys Acta       Date:  2001-03-21

Review 2.  Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis.

Authors:  I Vlodavsky; Y Friedmann
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

3.  Regional manifestations and control of the immune system.

Authors:  Soheyla Saadi; Lucile E Wrenshall; Jeffey L Platt
Journal:  FASEB J       Date:  2002-06       Impact factor: 5.191

4.  Heparanase expression in human leukemias is restricted to acute myeloid leukemias.

Authors:  Menachem Bitan; Aaron Polliack; Gabriella Zecchina; Arnon Nagler; Yael Friedmann; Liat Nadav; Varda Deutsch; Iris Pecker; Amiram Eldor; Israel Vlodavsky; Ben-Zion Katz
Journal:  Exp Hematol       Date:  2002-01       Impact factor: 3.084

5.  Multiple heparanases are expressed in polymorphonuclear cells.

Authors:  Mary Ann Kosir; Patricia A Foley-Loudon; Raphaela Finkenauer; Steven D Tennenberg
Journal:  J Surg Res       Date:  2002-03       Impact factor: 2.192

Review 6.  Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development.

Authors:  Israel Vlodavsky; Orit Goldshmidt; Eyal Zcharia; Ruth Atzmon; Zehava Rangini-Guatta; Michael Elkin; Tamar Peretz; Yael Friedmann
Journal:  Semin Cancer Biol       Date:  2002-04       Impact factor: 15.707

7.  Heparanase improves mouse embryo implantation.

Authors:  Ariel Revel; Aharon Helman; Moriah Koler; Asher Shushan; Orit Goldshmidt; Eyal Zcharia; Helena Aingorn; Israel Vlodavsky
Journal:  Fertil Steril       Date:  2005-03       Impact factor: 7.329

8.  Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies.

Authors:  O Ostrovsky; M Korostishevsky; I Levite; M Leiba; H Galski; I Vlodavsky; A Nagler
Journal:  Leukemia       Date:  2007-07-05       Impact factor: 11.528

9.  Activation, processing and trafficking of extracellular heparanase by primary human fibroblasts.

Authors:  Liat Nadav; Amiram Eldor; Oron Yacoby-Zeevi; Eli Zamir; Iris Pecker; Neta Ilan; Benjamin Geiger; Israel Vlodavsky; Ben-Zion Katz
Journal:  J Cell Sci       Date:  2002-05-15       Impact factor: 5.285

Review 10.  Candidate genes and single nucleotide polymorphisms (SNPs) in the study of human disease.

Authors:  S Chanock
Journal:  Dis Markers       Date:  2001       Impact factor: 3.434

View more
  12 in total

1.  Heparanase polymorphisms: influence on incidence of hepatic sinusoidal obstruction syndrome in children undergoing allogeneic hematopoietic stem cell transplantation.

Authors:  Claudia Seifert; Susan Wittig; Clemens Arndt; Bernd Gruhn
Journal:  J Cancer Res Clin Oncol       Date:  2014-10-22       Impact factor: 4.553

2.  Modification of heparanase gene expression in response to conditioning and LPS treatment: strong correlation to rs4693608 SNP.

Authors:  Olga Ostrovsky; Avichai Shimoni; Polina Baryakh; Yan Morgulis; Margarita Mayorov; Katia Beider; Anna Shteingauz; Neta Ilan; Israel Vlodavsky; Arnon Nagler
Journal:  J Leukoc Biol       Date:  2013-12-06       Impact factor: 4.962

Review 3.  Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.

Authors:  Uri Barash; Victoria Cohen-Kaplan; Ilana Dowek; Ralph D Sanderson; Neta Ilan; Israel Vlodavsky
Journal:  FEBS J       Date:  2010-08-31       Impact factor: 5.542

Review 4.  Involvement of heparanase in atherosclerosis and other vessel wall pathologies.

Authors:  Israel Vlodavsky; Miry Blich; Jin-Ping Li; Ralph D Sanderson; Neta Ilan
Journal:  Matrix Biol       Date:  2013-03-13       Impact factor: 11.583

5.  Genetic variations in the heparanase gene (HPSE) associate with increased risk of GVHD following allogeneic stem cell transplantation: effect of discrepancy between recipients and donors.

Authors:  Olga Ostrovsky; Avichai Shimoni; Avital Rand; Israel Vlodavsky; Arnon Nagler
Journal:  Blood       Date:  2010-01-14       Impact factor: 22.113

Review 6.  Role of non-HLA gene polymorphisms in graft-versus-host disease.

Authors:  Akiyoshi Takami
Journal:  Int J Hematol       Date:  2013-08-15       Impact factor: 2.490

7.  Polymorphisms and a haplotype in heparanase gene associations with the progression and prognosis of gastric cancer in a northern Chinese population.

Authors:  Ai-Lin Li; Yong-Xi Song; Zhen-Ning Wang; Peng Gao; Yuan Miao; Jin-Liang Zhu; Zhen-Yu Yue; Hui-Mian Xu
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

8.  The association between individual SNPs or haplotypes of matrix metalloproteinase 1 and gastric cancer susceptibility, progression and prognosis.

Authors:  Yong-Xi Song; Xin Zhou; Zhen-Ning Wang; Peng Gao; Ai-Lin Li; Ji-Wang Liang; Jin-Liang Zhu; Ying-Ying Xu; Hui-Mian Xu
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

9.  Identification of strong intron enhancer in the heparanase gene: effect of functional rs4693608 variant on HPSE enhancer activity in hematological and solid malignancies.

Authors:  Olga Ostrovsky; Ania Hava Grushchenko-Polaq; Katia Beider; Margarita Mayorov; Jonathan Canaani; Avichai Shimoni; Israel Vlodavsky; Arnon Nagler
Journal:  Oncogenesis       Date:  2018-06-29       Impact factor: 7.485

10.  Association of polymorphisms in the heparanase gene (HPSE) with hepatocellular carcinoma in Chinese populations.

Authors:  Lixia Yu; Xiaoai Zhang; Yun Zhai; Hongxing Zhang; Wei Yue; Xiumei Zhang; Zhifu Wang; Hong Zhou; Gangqiao Zhou; Feng Gong
Journal:  Genet Mol Biol       Date:  2017-10-02       Impact factor: 1.771

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.